Finoriq research workspace

Ainos, Inc. (AIMD) Company Overview

Ainos, Inc. offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to. Review AIMD filings, fundamentals, valuation, and ownership on Finoriq.

Company Snapshot

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Company

Ainos, Inc. (AIMD)

Ticker

AIMD

Market Cap

$13.6M

Latest Price

$1.60

Industry

Computer Hardware

Open insider transactions

Ainos, Inc. (AIMD) Current Valuation Metrics

Static valuation preview for Ainos, Inc. (AIMD). Market data retrieved 2026-07-09. Filing currency USD.

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.